4//SEC Filing
Novartis Institutes for BioMedical Research, Inc. 4
Accession 0001104659-17-073312
CIK 0001652130other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 12:19 PM ET
Size
6.9 KB
Accession
0001104659-17-073312
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2017-12-12$18.30/sh−1,523,000$27,870,900→ 4,129,903 total
Footnotes (2)
- [F1]The price reported in Column 4 is exclusive of any fees, commissions or other expenses.
- [F2]The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001673852
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 12:19 PM ET
- Size
- 6.9 KB